Back to Search Start Over

Health related quality of life in patients with community-acquired pneumococcal pneumonia in France

Authors :
Grèce Saba
Luiz Flavio Andrade
Hajnal-Gabriela Illes
Patrick Petitpretz
Jonathan Messika
Bruno Detournay
Pierre Bonnin
Gérard de Pouvourville
Henri Laurichesse
J. Gaillat
Christian Chidiac
Jean-Damien Ricard
ESSEC Business School
Essec Business School
Ecologie et Evolution des Microorganismes (EEM)
Université Paris Diderot - Paris 7 (UPD7)-Université Paris 13 (UP13)-Université Sorbonne Paris Cité (USPC)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Hôpital Louis Mourier - AP-HP [Colombes]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Service des Maladies Infectieuses
Centre Hospitalier de la Région d'Annecy (Pringy)
Université Grenoble Alpes - UFR Médecine (UGA UFRM)
Université Grenoble Alpes [2016-2019] (UGA [2016-2019])
Immunité infection vaccination (I2V)
Université Claude Bernard Lyon 1 (UCBL)
Université de Lyon-Université de Lyon-IFR128-Institut National de la Santé et de la Recherche Médicale (INSERM)
Service des Maladies Infectieuses et Tropicales [CHU Clermont-Ferrand]
CHU Gabriel Montpied [Clermont-Ferrand]
CHU Clermont-Ferrand-CHU Clermont-Ferrand
ESSEC
Source :
Health and Quality of Life Outcomes, Health and Quality of Life Outcomes, BioMed Central, 2018, 16 (1), ⟨10.1186/s12955-018-0854-6⟩, Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-14 (2018)
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

Background Community Acquired Pneumococcal Pneumonia is a lung infection that causes serious health problems and can lead to complications and death. The aim of this study was to observe and analyze health related quality of life after a hospital episode for patients with community acquired pneumococcal pneumonia in France. Methods A total of 524 individuals were enrolled prospectively in the study and were followed for 12 months after hospital discharge. Presence of streptococcus pneumoniae was confirmed by microbiological sampling. Quality of life was reported at four different points of time with the EQ-5D-3 L health states using the French reference tariff. Complete data on all four periods was available for 269 patients. We used descriptive and econometric analysis to assess quality of life over time during follow-up, and to identify factors that impact the utility indexes and their evolution through time. We used Tobit panel data estimators to deal with the bounded nature of utility values. Results Average age of patients was 63 and 55% of patients were men. Negative predictors of quality of life were the severity of the initial event, history of pneumonia, smokers, age and being male. On average, quality of life improved in the first 6 months after discharge and stabilized beyond. At month 1, mean utility index was 0.53 (SD: 0.34) for men and 0.45 (SD: 0.34) for women, versus mean of 0.69 (SD: 0.33) and 0.70 (SD: 0.35) at Month 12. “Usual activities” was the dimension the most impacted by the disease episode. Utilities for men were significantly higher than for women, although male patients were more severe. Individuals over 85 years old did not improve quality of life during follow-up, and quality of life did not improve or deteriorated for 34% of patients. We found that length of hospital stay was negatively correlated with quality of life immediately after discharge. Conclusion This study provides with evidence that quality of life after an episode of community acquired pneumococcal pneumonia improves overall until the sixth month after hospital discharge, but older patients with previous history of pneumonia may not experience health gains after the initial episode.

Details

Language :
French
ISSN :
14777525
Database :
OpenAIRE
Journal :
Health and Quality of Life Outcomes, Health and Quality of Life Outcomes, BioMed Central, 2018, 16 (1), ⟨10.1186/s12955-018-0854-6⟩, Health and Quality of Life Outcomes, Vol 16, Iss 1, Pp 1-14 (2018)
Accession number :
edsair.doi.dedup.....9493673b366a9d02897c4bde19d6e491